pancreatic cancer
Conditions
Interventions
stellate ganglion block group:Right stellate ganglion block with 0.35% ropivacaine combined with 0.025% dexamethasone, total 3 mL
control group:Right stellate ganglion block with 3ml of saline
Sponsors
Zhejiang Cancer Hospital
Eligibility
Sex/Gender
All
Age
18 Years to 75 Years
Inclusion criteria
Inclusion criteria: 1.Sign the informed consent form; 2.Patients who are scheduled to undergo bipolar synchronous burst pulse therapy instrument ablation for pancreatic cancer 3.Age 18-75 years old; 4.ASA grade I-III;
Exclusion criteria
Exclusion criteria: 1. Those who have contraindications to regional blockade techniques (allergic to local anesthetics, infected around the puncture site, those with coagulation disorders: such as PLT 1.5); 2. Those who have any cerebrovascular accident, such as stroke or transient ischemic attack (TIA), within 3 months; 3. Patients with language communication disorders or psych; 4. Patients with severe bradycardia or II-III degree atrioventricular block; 5. Those who have contraindications to the study and other anesthetic drugs; Those who are determined/suspected of abusing anesthetic sedatives and analgesics; 6. Researchers who withdraw from the study on their own 7. Epilepsy patients;
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Incidence of perioperative cardiovascular events; | — |
Secondary
| Measure | Time frame |
|---|---|
| Postoperative myocardial injury markers; | — |
Countries
China
Contacts
Public ContactCui Xiaoying
Zhejiang Cancer Hospital
Outcome results
None listed